Crystal Bioscience is a privately-held company that was founded in 2008 to develop a therapeutic antibody discovery engine using chickens. Its platform relies on the large phylogenetic distance between mammals and birds to generate a diverse array of antibodies to human targets that have proven intractable in mammalian and other discovery platforms.

Affymetrix, Inc. was an American company that manufactured DNA microarrays; it was based in Santa Clara, California, United States. The company was acquired by Thermo Fisher Scientific in March 2016. The company was founded by Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, which had in the late 1980s developed methods for fabricating DNA microarrays, called "GeneChip" according to the Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996. As a result of its pioneering work and the ensuing popularity of microarray products, Affymetrix derived significant benefit from its patent portfolio in this area.

Chiome Bioscience was established in 2005 to commercialize the innovative ADLib® antibody generation technology invented at RIKEN. Since that time the Company has worked on research and development for this system, as well as initiatives for technology licensing. It focused mainly on joint research and contract research with the research arms of pharmaceutical companies and academia. Meanwhile, in 2011 the Company was listed on the Mothers market of the Tokyo Stock Exchange, and in 2015 it merged with LivTech which focused on drug discovery and development of therapeutic antibody for oncology, thus adding drug discovery function. In 2017 the Company went through reorganization of the management team, switching its strategy from platform development to drug discovery and development. At the same time it started setting up the clinical function which enables us to run a clinical study aiming of significant increase in corporate value.

Sirna Therapeutics, Inc. was a San Francisco, California based biotechnology company that explored the use of RNA interference in human disease therapy. Sirna's development pipeline includes several small interfering RNA (siRNA) drugs, thought to stably silence the expression of specific disease-related genes. Sirna's clinical trial of an siRNA-based treatment for age-related macular degeneration is the first such trial for an siRNA drug.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Counsyl is a health technology company that offers DNA screening for men, women and their children. Our philosophy is simple - focus on diseases where advanced knowledge makes a difference in health outcomes, whether it's changing a behavior, pursuing preventative measures, or simply preparing for what lies ahead. Counsyl has screened over 500,000 patients and served over 6,000 health professionals in its modern clinical laboratory. From the purely mechanical to profoundly human, Counsyl strives to make DNA screening truly accessible to everyone. The team consists of world class engineers, scientists and clinical experts as well as a renowned engineering and scientific advisory board. Counsyl integrates sophisticated technology with custom robotic automation in its accredited medical laboratory. This focus on technology has made Counsyl a leader in helping patients and doctors communicate about medical results in real time. Its products have won the Wall Street Journal’s Innovation Award for Medicine, and have been named one of Scientific American's "Top 10 World Changing Ideas." Counsyl’s Family Prep Screen has already helped hundreds of thousands of people discover critical information before having children, and the Counsyl platform now extends beyond family preparation to include informed pregnancy and cancer screening.

Cetus Corporation was one of the first biotechnology companies. It was established in Berkeley, California in 1971, but conducted most of its operations in nearby Emeryville. Before merging with another company in 1991, it developed several significant pharmaceutical drugs as well as a revolutionary DNA amplification technique.

Hitachi High-Tech America, Inc., a subsidiary of Hitachi Ltd., is an American company located in Schaumburg, IL, that manufactures semiconductor manufacturing equipment, industrial equipment & electronic devices.

Suzhou Semico Gene Technology Co., Ltd., established on 2016-04-22, Business scope includes gene technology development,technical consulting,Technical Services,technology transfer;Conference Services;product design;software development;Application software service;Natural science research and experimental development;Medical Research and Experimental Development;Sell ​​self-developed products.Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

A/F Protein, Inc. engages in the production and sale of antifreeze proteins purified from natural sources. It offers antifreeze protein types I and III as well as antifreeze glycoprotein. The company was founded by Elliot Z. Entis, Boris Rubinsky, Garth L. Fletcher, and Choy L. Hew in 1992 and is headquartered in Waltham, MA.

Siemens Healthcare Diagnostics, Inc. engages in the vitro diagnostics. It provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the vital information required to accurately diagnose, treat, and monitor patients. The company is headquartered in Tarrytown, NY.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Beijing Sensetime Technology Development Co. Ltd. is a Chinese private company. The firm develops artificial intelligence based mobile application software.

Geno Dive Pharma provides various types of Health Care, Pharmaceutical & Biotechnology services.

UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

Molecular Loop is a biotechnology company that specializes in DNA sequencing. With its Molecular Loop targeting, a separate library prep process is not needed. Amplicons are designed to tile across each target on both strands with a high degree of overlap, for sequence data without the extra work and expense of making a shotgun library.

Weihansi Shengwu is engaged in genetic disease screening and diagnosis, abortion product detection, single gene blockade of new mutations, and a technical service platform for gene detection of genetic diseases and the prevention and control of birth defects.

CarrierGene Biotech Co., Ltd. engages in the identification of the causes of infertility for patients through genetic testing technology and data analysis algorithms. The company was founded in 2016 and is headquartered in Suzhou, China.

BGI Tech Solutions Co., Ltd. (BGI-Tech), is a world leader in cutting-edge life sciences technology and premier scientific partner to the global research community. With a firm commitment to providing the highest quality services through our worldwide service network, BGI-Tech’s mission is to facilitate ground-breaking research, foster productive collaboration and accelerate scientific advancement. BGI-Tech was founded in 2012 and is headquartered in Shenzhen, China. BGI-Tech has lab facilities in Hong Kong, Wuhan (China),and Sacramento, California (United States). It also has branch offices in Europe, the Americas, Asia- Pacific, and in Beijing, Shanghai, and Guangzhou of mainland China. Its service network covers more than 100 countries and regions. Currently, BGI-Tech collaborates with over 10,000 organizations and 30,000 partners, providing highly reliable services for thousands of research projects, including several large-scale international genome projects. With diverse service experience, unique scientific expertise, BGI-Tech is committed to developing integrated omics platforms to revolutionize life science research, to accelerate the advancement of the life science industry and to address various health, agricultural, energy, and environmental issues to improve life and society.